Skip to content

Sarepta Therapeutics, Inc. SRPT Short-Term Investments

Short-Term Investments at other companies

Pfizer logo
PfizerPFE
$11.37B-28.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.79B+10.1%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$0-100%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$1.06B+93.5%
Insmed logo
InsmedINSM
$641.33M-19.5%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
$173.19M+49.3%

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.76B-63.1%

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s short-term investments?
Sarepta Therapeutics, Inc. (SRPT) reported short-term investments of $188.74M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s short-term investments changed year-over-year?
Sarepta Therapeutics, Inc.'s short-term investments decreased by 33.0% year-over-year, from $281.9M to $188.74M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s short-term investments?
Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s short-term investments has grown at a -20.5% compound annual growth rate (CAGR), from $435.92M to $138.37M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.